おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
OxVax
company
About
OxVax focused on the development of an advanced next-generation dendritic cell vaccine platform for the treatment of solid tumor cancers.
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Biotechnology,Therapeutics
- Founded date
- Jan 1, 2021
- Operating Status
- Active
OXvax Ltd. is a spin-out company from the University of Oxford focused on the development of an advanced next-generation dendritic cell vaccine platform for the treatment of solid tumor cancers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
OxVax has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Apr 21, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 21, 2021 | Seed | — | 2 |
Evotec
Lead Compass Investment
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
OxVax is funded by 2 investors.
Evotec
and Lead Compass Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Evotec
|
Yes | Seed |
|
Lead Compass Investment
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
